186551-69-9 Usage
Description
3-BROMOMETHYL-PYRAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is a pyrazole derivative featuring a tert-butyl ester functional group and a bromomethyl substituent. This chemical compound is utilized in the pharmaceutical and agricultural industries for its unique structural properties and potential in drug discovery and crop protection.
Used in Pharmaceutical Industry:
3-BROMOMETHYL-PYRAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a building block for the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new chemical entities for drug discovery, contributing to the modulation of biological targets and enhancement of pharmacological properties.
Used in Agricultural Industry:
In the agricultural sector, 3-BROMOMETHYL-PYRAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a precursor in the synthesis of agrochemicals. Its role in creating new chemical entities aids in the advancement of crop protection strategies, ensuring the development of effective and innovative solutions for agricultural challenges.
Used in Medicinal Chemistry:
3-BROMOMETHYL-PYRAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is utilized as a valuable component in medicinal chemistry. Its ability to modulate biological targets makes it a promising candidate for the development of new drugs and therapeutic agents, further expanding its applications in the field of drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 186551-69-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,5,5 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 186551-69:
(8*1)+(7*8)+(6*6)+(5*5)+(4*5)+(3*1)+(2*6)+(1*9)=169
169 % 10 = 9
So 186551-69-9 is a valid CAS Registry Number.
186551-69-9Relevant articles and documents
COMPOUNDS AS GLP-1R AGONISTS
-
Paragraph 0398; 0400, (2022/03/07)
The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Also provided are pharmaceutical compositions containing such compounds, or stereoisomers, tautomers, or pharmaceutically acceptable salts of any of the foregoing. Methods of prepare these compounds and compositions and method of using them to treat or present a disease or a condition mediated by GLP-1R.
INHIBITORS OF HIF PROLYL HYDROXYLASE
-
Page/Page column 30, (2016/04/20)
The present invention concerns compounds of formula I or pharmaceutically acceptable salts thereof, which inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as anemia and like conditions, as well as pharmaceutical compositions comprising such a compound and a pharmaceutical carrier.
NOVEL ANTIVIRAL PYRROLOPYRIDINE DERIVATIVE AND A PRODUCTION METHOD FOR SAME
-
Page/Page column 0309; 0310; 0311; 0312; 0313, (2014/12/09)
The present invention relates to a pyrrolopyridine derivative represented by the Chemical Formula I, and a racemate or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and relates to an antiviral composition including the same as an active ingredient. The compound of the Chemical Formula I has excellent antiviral activity and selectivity for wild type and resistant HIV-1, and thereby is useful as a therapeutic agent for acquired immune deficiency syndrome (AIDS).
